BRL 26830A and weight loss.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D001835:Body Weight; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009765:Obesity / Q000188:drug therapy*
D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; C039248:BRL 26830A